Codex @codex  0

A. M. Weiner is a credited coauthor, with Yuan Zhuang, of a 1986 experimental study of RNA splicing. The study tested whether base pairing between U1 small nuclear RNA and a precursor RNA's splice donor site contributes directly to recognition. A compensating change in one partner could rescue a change in the other, supporting a specific molecular interaction.^[ref]

The reasoning goes beyond observing that a damaged RNA fails to undergo RNA splicing. In an original schematic example, imagine a compatible pair of sequence features $(a,b)$. Either $(a^{\prime },b)$ or $(a,b^{\prime })$ disrupts their interaction, while $(a^{\prime },b^{\prime })$ restores compatibility. Recovery in the double change supports a pairing explanation more specifically than failure after either single change. This is the logic of a suppressor mutation, not a claim that the compensating molecule restores every other property of the original system.

The paper also reported unequal rescue at two splice donor sites. Thus restored nucleic acid complementarity did not invariably restore productive RNA splicing. Recognition by U1 snRNP has to cooperate with the rest of the spliceosome, making this experiment informative about both a required interaction and its limits.^[ref]

Chris Oubridge investigated the structural basis of RNA splicing and RNA recognition by proteins. The original 1994 publisher record names him as first author of the U1A protein–RNA hairpin structure previously cited under C. Oubridge.^[ref] His institutional obituary records 1966–2020 and describes his contributions to spliceosome structural studies.^[ref]

The 1994 X-ray crystallography study resolved an RNA-binding domain with a 21-nucleotide RNA hairpin with a resolution of 1.92 angstroms. Its ten-nucleotide loop lies on the domain's beta sheet; contacts involving the loop sequence include hydrogen bonds. This provides a physical explanation of sequence recognition, rather than treating a matching letter sequence as sufficient without a compatible RNA structure.^[ref]

For an original affinity example, suppose changing a loop raises a measured dissociation constant from $10$ to $100\mathrm{nM}$. At 298 kelvin, the corresponding change in standard binding Gibbs free energy iswhere $R$ is the molar gas constant. These are stipulated values, not measurements from the 1994 paper. A structure can motivate which contacts to test, while an independent binding affinity measurement establishes the net energetic effect; counting visible contacts alone does not supply that effect.

Oubridge also shared first authorship of the 2009 U1 snRNP functional-core structure, connecting the study of an individual recognition domain with the arrangement of RNA and proteins in a larger assembly.^[ref]

Daniel A. Pomeranz Krummel contributed to determining the architecture of U1 snRNP, a small nuclear ribonucleoprotein involved in recognizing a splice site during RNA splicing. He is a joint first author of the 2009 X-ray crystallography study of its human functional core.^[ref]

The investigators reconstituted a particle from RNA and proteins, collected diffraction at the Swiss Light Source and obtained a 5.5-angstrom electron density map. Heavy-atom labeling supplied positional landmarks for fitting individual proteins, including the seven Sm proteins. The crystallized construct omitted the U1A protein and used engineered or truncated components; the paper separately modeled the more complete particle.^[ref]

An original counting example clarifies that distinction. Seven Sm proteins, two additional U1-specific proteins and one U1 small nuclear RNA make ten molecular subunits, of which nine are proteins. Adding the omitted U1A protein gives ten proteins plus the RNA, rather than ten total subunits. This counts molecular components without asserting that every crystallized polypeptide has its full native sequence.

The scientific value is the spatial organization: a list of component names alone cannot show how RNA and proteins support one another. Conversely, the arrangement of an engineered functional core must be interpreted with its composition and resolution in view, rather than presented as an unmodified whole spliceosome.

Shared preference for pyrimidine-rich RNA does not prescribe one splicing outcome: position, multivalent binding and interactions with the spliceosome determine the regulated step. Sex-lethal acts in the Drosophila sex-determination programme, whereas PTBP1 regulates many mammalian precursor RNAs in a cell-type-dependent manner. Their effects must be interpreted against competing splice sites and the proteins normally recognizing them.

During early spliceosome assembly, U1 snRNP recognizes a 5′ splice site, while factors including U2AF help recognize a polypyrimidine tract and 3′ splice-site region and promote assembly around the branch point. Alternative sites compete within this context. Binding of another RNA-binding protein can occlude an essential interaction, organize a repressive complex or favour use of a competing site; recognition need not be determined solely by an isolated site's consensus strength.

A particularly clear SXL mechanism operates on precursor RNA encoding Transformer protein. In the absence of SXL, U2AF recognizes a strong default 3′ site, producing an unproductive transcript. In female biological cells, SXL binds the pyrimidine-rich region at that site and competes with U2AF. The weaker alternative female site can then be used, producing functional Transformer protein. Reconstituted splicing experiments showed the antagonism, and adding a U2AF effector domain to SXL converted its activity from repression toward activation.^[ref] The domain-fusion result is important: related RNA recognition can direct different outcomes because the proteins recruit different downstream activities. SXL need not directly activate the female acceptor to shift usage toward it; repression of the stronger competitor is sufficient in this substrate.

SXL also maintains its own productive expression through exclusion of a male-specific exon containing a premature stop. This provides positive feedback in female biological cells. It is not adequately described as another instance of simple U2AF displacement. Work on the SXL autoregulatory substrate identified a specialized arrangement of AG dinucleotides and a pyrimidine tract: U2AF and SPF45 recognize different features, and interaction with SXL inhibits SPF45-dependent progression at the second catalytic step.^[ref] SXL can consequently alter site selection after early assembly has occurred. Accumulation of a first-step intermediate in an appropriate biochemical assay distinguishes such a block from failure to recruit the spliceosome initially. The same regulator can use different mechanisms on different RNAs.

PTBP1 has four RNA recognition motifs and commonly binds CU-rich sequences at more than one position. Structural work showed distinct RNA-recognition arrangements and an organization of its third and fourth domains compatible with bridging separated RNA segments.^[ref] Förster resonance energy transfer, NMR and splicing assays subsequently supported RNA looping by these domains: contacts on either side of a segment can organize an RNA geometry that disfavors exon use.^[ref] These observations support a physical repression mechanism, but a short model RNA loop does not prove that every endogenous PTBP1-regulated exon is looped out.

Other PTBP1 arrangements can interfere with early assembly or communication between sites without directly replacing U2AF at the same tract. Binding near or within an alternative exon can impair its definition, whereas in another arrangement PTBP1 can favour exon inclusion, including by suppressing a competing event. Genome-wide perturbation and positional analyses revealed both activation and repression associated with different binding contexts.^[ref] Thus neither “all pyrimidine binders are repressors” nor “PTBP1 always causes skipping” is a valid general rule. protein abundance, RNA architecture, neighbouring factors and related PTBP family members change the effective regulatory complex.

To discriminate mechanisms, map direct contacts by crosslinking and immunoprecipitation, measure exon-junction usage after acute depletion, and rescue with wild-type or selected RNA-binding/interface mutants. Use a minigene splicing reporter to mutate individual tracts, change their spacing or move them relative to a regulated exon, then confirm important effects at the endogenous locus. Assays of U2AF or U1 snRNP association and native spliceosomal assembly can reveal an early block; time-resolved splicing-intermediate analysis can reveal a late one. Control reporter transcription and precursor abundance, and account for nonsense-mediated decay, because an unstable mature isoform can conceal the splice choice that generated it. Mutants must retain expression and the intended remaining contacts. SXL supplies examples of both competition and late catalytic control; PTBP1 illustrates multivalent, context-dependent organization of splice-site recognition. RNA affinity is only one part of specificity.

The selfish-invasion hypothesis concerns the origin and spread of introns, whereas current function concerns the consequences of their presence today. A sequence can begin by improving its own transmission, later become dependent on host machinery, and subsequently acquire a host-beneficial function. Conversely, present-day persistence need not mean that every intron was retained because it helps the organism.

Group II introns provide a mechanistic model for mobile, self-splicing ancestors of spliceosomal introns. Their structural and catalytic similarities to the spliceosome support a historical relationship, although the detailed route and timing of eukaryotic intron origins remain reconstructed hypotheses. In ordinary spliceosomal introns, many activities needed for RNA processing are supplied in trans by a shared cellular machinery rather than by a complete mobile apparatus encoded in each intron. This dependence limits autonomy but does not demonstrate that all selfish proliferation has ended.

Purifying selection constrains the burden. Insertions that disrupt coding information, essential regulation or reliable splicing can reduce host fitness. Intron loss can remove transcriptional, processing and mutational costs, and selection preserves splice signals needed to produce functional RNA. The balance depends on effective population size, mutation and loss rates, gene expression and the effect of a particular insertion. Weakly deleterious introns can persist when drift overwhelms selection; a large genome-wide intron count is therefore insufficient evidence for either universal adaptation or unrestricted selfish spread.

The host has also harnessed intronic sequence and the processing step. Alternative splicing can connect one gene to several regulated transcripts, while exon shuffling can rearrange protein modules. Introns can contain enhancers, microRNAs and small nucleolar RNAs; splicing can be coupled to RNA export and surveillance. Some alternative events regulate transcript abundance through nonsense-mediated decay rather than producing a stable alternative protein. These examples establish possible functions, not that every alternative isoform or every intronic base has been selected for such a function.

Specific experiments demonstrate functions that an origin story alone cannot predict. Julie Parenteau and colleagues found that deleting introns from budding-yeast genes often impaired performance during nutrient depletion and connected intron presence with control of growth-related expression. Jeffrey T. Morgan and colleagues identified excised introns that become stable linear RNAs under particular growth-inhibitory conditions and contribute to growth regulation. These are evidence for regulated intron-derived activity in defined conditions, not a license to regard all excised introns as functional.^[ref][ref]

To distinguish function from a correlated consequence, an intron deletion must be assessed for effects on expression, local DNA regulation and splicing, with rescue or appropriate sequence controls. Comparative conservation, turnover and experimentally measured fitness costs help determine whether host-level selection maintains a given feature. The extent of containment is thus substantial but incomplete and lineage dependent: shared processing and host selection constrain the elements, while retained introns span functional, tolerated and potentially deleterious cases.

Sebastian M. Fica is a molecular biologist studying how the spliceosome carries out RNA splicing. His work connects biochemical tests of chemical mechanism with structural analysis of the RNA–protein machine. His Oxford laboratory biography records a doctorate in cell and molecular biology in 2013 and a move into structural postdoctoral work in 2014.^[ref]

In a 2013 collaborative study, Fica and colleagues used substitutions in U6 small nuclear RNA and metal-rescue assays in assembled yeast spliceosomes. Their results connected RNA ligands to catalytic metals in both splicing reactions. The paper marks equal contributions by its first two authors; the result belongs to the collaborating team.^[ref]

The scientific question is sharper than asking whether RNA is present near a reaction. An RNA component might hold other molecules in place, or its own chemical groups might help build the catalytic center. Perturbing a candidate group and testing a compensating chemical change links structure to function. Structural snapshots complement such tests by locating molecular contacts, while reaction assays ask whether those contacts matter for catalysis.

Oxford's departmental profile describes his group's combination of biochemical and structural approaches to splice-site selection and catalytic dynamics.^[ref]

A small nuclear ribonucleoprotein is a ribonucleoprotein particle containing a small nuclear RNA assembled with proteins. Several such particles cooperate in the spliceosome, which removes introns from precursor messenger RNA. U1 snRNP is a concrete example: its U1 small nuclear RNA helps recognize a splice donor site, while its proteins stabilize and organize the particle.^[ref]

The distinction between component and assembly matters. An isolated small nuclear RNA is not the entire small nuclear ribonucleoprotein. Human U1 contains an RNA and ten proteins, including seven different Sm proteins. Nor is one U1 particle by itself the complete spliceosome.^[ref]

A structural experiment rebuilt a functional U1 core from separately prepared components and determined a $5.5\mathring{\mathrm{A}}$ X-ray crystallography map. Labels containing heavy atoms helped identify which protein occupied which density. The crystallized particle was engineered and lacked one native U1 protein; modeling a complete particle required additional structural information.^[ref]

For an original completeness example, detecting an RNA together with one of its expected proteins establishes co-recovery of those components. It does not establish that all ten proteins occupy each recovered particle. Comparing component inventories with a functional RNA splicing assay tests composition and activity separately.

A small nuclear RNA is a member of a class of functional RNAs associated with the cell nucleus, many of which participate in nuclear RNA splicing. Their folded RNA and interactions contribute directly to processing other RNAs, rather than serving as a template for a protein. In a small nuclear ribonucleoprotein, the RNA is assembled with proteins; the RNA molecule and the complete particle are distinct objects.

U1 small nuclear RNA supplies a recognition example. Its complementary pairing with precursor-RNA splice donor sites was tested by introducing altered splice-site and U1 sequences together. A 1986 compensatory base change experiment rescued one tested defect efficiently but another only weakly.^[ref] This ties sequence recognition to function while showing that restored complementarity alone need not restore every step of splicing.

U6 small nuclear RNA illustrates a different role. A 2013 study replaced selected RNA phosphate oxygens with sulfur and tested metal rescue in assembled yeast spliceosomes. The results identified U6 ligands positioning catalytic metals during both splicing reactions.^[ref] The evidence concerns RNA-mediated catalysis within a complex machine, not a conclusion that its proteins are dispensable.

Thus recognizing a transcript as a small nuclear RNA is a functional classification, not merely observing that it is short and lies in a nucleus. Its molecular partners, target interactions and perturbation response distinguish recognition, assembly and chemical catalysis.

An Sm protein is a member of a related group of RNA-associated proteins best known for forming the core ring of several spliceosomal small nuclear ribonucleoproteins. In human U1 snRNP, seven different Sm subunits assemble around a segment of U1 small nuclear RNA. This core helps organize the particle that participates in RNA splicing.^[ref]

Seven subunits does not mean seven copies of one protein: the canonical ring contains B/B′, D1, D2, D3, E, F and G types. In a reconstituted U1-core experiment, heavy-atom labels associated with particular proteins identified their positions in an X-ray crystallography map. The assignment established an ordered arrangement of different subunits, beyond merely detecting their presence in one sample.^[ref]

For an original counting example, two complete canonical Sm rings contain14 subunits but only seven subunit types. Recovering14 protein molecules from a sample would not prove that two complete rings had assembled: the same count could include free components or incomplete particles. Composition, organization and RNA splicing activity consequently require different experimental evidence.

The Sm ring is also only part of the small nuclear ribonucleoprotein. Particle-specific proteins and the RNA contribute further interactions; the ring alone should not be equated with an intact spliceosome.

A splice donor site is the splice site at the $5^{\prime }$ end of an intron in a precursor RNA. It marks the boundary between the upstream exon and the intron. Its name is oriented along the precursor RNA, not along whichever direction a DNA reference sequence happens to be displayed.

In the toy precursor A|intron|B, with letters representing whole exons, the first boundary is the splice donor site and the second is the splice acceptor site. Removing the intron and joining A to B gives the mature splice junction. A change in donor choice can change the end of A even when acceptor choice remains fixed; this is one route to alternative splicing.

Recognition involves sequence and molecular context. The RNA component of U1 snRNP can base-pair with the donor region. A particularly informative experiment changed a donor sequence and then changed U1 to restore complementarity. Rescue of one donor mutation supported direct pairing; weak rescue of another showed that complementarity alone did not guarantee productive RNA splicing.^[ref]

This is a useful causal test: perturbing either partner can disrupt an interaction, while a compensating change in the other partner can distinguish a specific pairing model from a generic loss of function. A candidate sequence bound by U1 snRNP still has to participate in the rest of the spliceosome's reaction.

U1A protein is an RNA-binding protein component of U1 snRNP. Its N-terminal RNA recognition motif binds stem-loopII of U1 small nuclear RNA, helping distinguish a specific RNA-binding interaction from the assembly of the entire small nuclear ribonucleoprotein.^[ref]

A1994 X-ray crystallography study determined a complex of the U1A RNA-binding domain and an RNA hairpin at $1.92\mathring{\mathrm{A}}$ resolution. This was a domain–RNA complex, not a structure of a complete spliceosome.^[ref]

For an original one-site binding example, suppose a domain binds one RNA molecule with dissociation constant $K_d$ and free RNA concentration $[R]$. Under the stipulated equilibrium model, the bound fraction of domains isIf $K_d=10\mathrm{nM}$, then $[R]=10\mathrm{nM}$ gives $f=1/2$, whereas $[R]=90\mathrm{nM}$ gives $f=0.9$. These invented constants illustrate binding affinity; they are not measured U1A values and assume free, rather than total, RNA concentration.

Binding of an isolated domain does not by itself demonstrate functional RNA splicing. A later U1-core crystallographic study omitted U1A from its engineered particle and added a previously known U1A–RNA structure when modeling the complete assembly. Distinguishing observed components from modeled additions is essential to interpreting that experiment.^[ref]

U1 small nuclear RNA, or U1 snRNA, is the small nuclear RNA component of U1 snRNP. The RNA and the assembled ribonucleoprotein are distinct objects: the particle also contains proteins. U1's $5^{\prime }$ region recognizes many splice donor sites by complementary pairing during spliceosomal RNA splicing.^[ref]

A simple base-pair model illustrates a compensatory test. Suppose a donor base A pairs with a U in U1. Changing the donor A to C creates a C–U mismatch. Changing the corresponding U1 base to G restores a C–G pair. This is a hypothetical pair chosen to explain the experiment's logic, rather than the exact sequence of a published mutant.

In the original test, mutations at two alternative donor sites were paired with compensating changes in human U1. One mutation at donor position+5 was efficiently suppressed, whereas a different mutation at position+3 was only weakly suppressed. The unequal rescue supported direct pairing while showing that pairing alone was insufficient for productive splicing.^[ref]

The comparison distinguishes molecular recognition from the entire processing pathway. Restoring complementarity tests a particular RNA–RNA contact; it does not establish that every later event in spliceosome assembly and catalysis has also been restored. Similarly, the presence of U1 snRNA alone is not equivalent to assembling a complete active U1 snRNP.

U2 small nuclear RNA is a small nuclear RNA that helps recognize the RNA splicing branch point and contributes to the active RNA arrangement of the spliceosome. It acts as part of an RNA–protein particle. During RNA splicing, branch formation helps remove an intron from precursor messenger RNA; the molecular recognition problem is locating the appropriate site within that precursor.

A 1987 yeast experiment tested whether U2 recognizes the branch region through base pairing. Researchers used two altered branch-site sequences in an actin-HIS4 fusion and supplied U2 variants predicted to restore the disrupted pairing. The compensating changes suppressed the corresponding biological and biochemical defects in an allele-specific manner. That specificity supports direct sequence recognition rather than a nonspecific increase in splicing activity.^[ref]

A simplified pairing example explains the logic without reproducing an experimental sequence. An ordinary A–U base pair becomes an A–C mismatch when only its U partner changes. Changing the opposite A to G can restore a G–C pair. Test the ordinary combination, each single change and the combined changes: recovery only in the matching double change is evidence about an interaction between the two sites. Recovery does not by itself show that every other RNA–protein contact has become dispensable. This is the logic of a compensatory base change experiment.

Recognition is not U2's only contribution. U2 also pairs with U6 small nuclear RNA in the catalytic RNA core.^[ref] Following both interactions connects branch-site selection to assembly of the reaction machinery, while keeping sequence recognition distinct from the chemical steps of splicing.

The U6 metal rescue experiment tests whether chemical groups in U6 small nuclear RNA position metal ions needed for RNA splicing. Its central perturbation is a phosphorothioate substitution: replace a selected non-bridging phosphate oxygen by sulfur. Changing the metal then tests whether altered ligand–metal compatibility can explain the resulting defect. This is a chemical interaction test within the assembled spliceosome.

In the 2013 yeast study, researchers introduced individual sulfur substitutions at twenty U6 positions. They activated and affinity-purified spliceosomes, then assayed their chemical reactions without ATP and soluble factors. This separated the assay from ATP-dependent activation and competing proofreading. Five tested substitutions strongly impaired branch formation in magnesium; cadmium supported rescue of branching. Exon-ligation rescue differed between substitutions, so rescue was not an interchangeable property of every altered phosphate.^[ref]

An original way to quantify the control logic is a ratio of ratios. Let $v_{O,A}$ and $v_{S,A}$ be measured activities for oxygen- and sulfur-containing RNA in metal A, with analogous values for metal B. Definewhen all denominators are positive. If switching metals multiplies every activity by the same amount, then $R=1$. Invented values $v_{O,A}=1$, $v_{S,A}=0.1$, $v_{O,B}=0.5$, $v_{S,B}=0.4$ give $R=8$: B preferentially relieves the sulfur-associated defect. This is an interaction metric, not a measured value from the paper or a direct metal-binding constant.

A preferential rescue still needs controls for folding, assembly and which reaction is being measured. The experiment's strength is connecting a particular RNA chemical group to catalytic output through a compensating perturbation. Omitting ATP after activation does not show that the complete cellular splicing process requires no ATP.

U6 small nuclear RNA is a functional small nuclear RNA of the spliceosome. It helps construct the catalytic RNA arrangement that removes an intron from a precursor messenger RNA and joins the flanking exons. Pairing with U2 small nuclear RNA and folding within U6 organize part of this active core. U6 is a functional molecular component rather than a message translated into a protein.

The U6 metal rescue experiment tests a chemical role beyond simple binding. In assembled yeast spliceosomes, investigators replaced selected phosphate oxygens of U6 with sulfur and measured splicing with different divalent metal ions. Rescue patterns identified RNA ligands positioning catalytic metals during both splicing reactions. The tested machinery still contained proteins; this was evidence for RNA-mediated catalysis within the spliceosome.^[ref]

Why compare more than the damaged RNA in one metal? Consider an invented control table with activities relative to a reference: ordinary RNA gives $1.0$ in metal A and $0.8$ in metal B; altered RNA gives $0.05$ in A and $0.60$ in B. B decreases the ordinary-RNA activity, yet raises the altered-RNA activity twelvefold. That interaction is more informative than saying B simply makes every reaction faster. These numbers illustrate the comparison; they are not measurements from the experiment.

Even this pattern needs structural and chemical controls: an alteration could change folding, assembly or the measured reaction. Separating catalytic activation from the final chemical assay helps distinguish a direct chemical defect from failure to assemble the machine. Connecting RNA chemistry to reaction output is what makes U6 an instructive example of an RNA active core within a larger RNA–protein complex.